.
.
.
 
 
 
.
Concord Biotech Limited is an R & D based biotechnology company having state of the art fermentation facility. Acquired by Mr. Sudhir Vaid , a biotechnologist with 29 years experience , from DSM a Dutch Multinational Company, it started operations in the year 2000 with the manufacturing of Penicillin-G Amidase immobilized enzyme using it's own polymer matrix. Using its expertise in the field of Biotechnology and chemistry, concord is concentrating on the fermentation-based products. Concord has diversified in the field of active pharmaceutical ingredients namely Lovastatin, Pravastatin, Simvastatin and Tacrolimus. Concord has provided number of technologies on biotech products to many companies in Europe & India. Concord has received USFDA approval for its lovastafin facilities and striving to go for EDMF shortly.
Concord Biotech Limited (CBL) offers fermentation services that rely on more than 30 years of experienced staff. CBL has the capacity and flexibility to ferment and develop processes for a variety of microbial organisms.
CBL is the largest producer of Penicillin-G Amidase enzyme and is exporting this enzyme to a number of companies in China , Europe, USA besides having 90% market share in India . CBL is also producing and exporting Lovastatin and Tacrolimus to Europe and other countries. It is also starting the production of Simvastatin and Pravastatin in its newly US-FDA approvable facility.